Creative Planning trimmed its stake in shares of Leidos Holdings, Inc. (NYSE:LDOS – Free Report) by 3.1% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 72,400 shares of the aerospace company’s stock after selling 2,347 shares during the quarter. Creative Planning owned about 0.05% of Leidos worth $10,562,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently modified their holdings of LDOS. 1832 Asset Management L.P. bought a new stake in shares of Leidos during the 2nd quarter worth about $34,000. Blue Trust Inc. boosted its holdings in shares of Leidos by 251.3% during the second quarter. Blue Trust Inc. now owns 281 shares of the aerospace company’s stock worth $41,000 after acquiring an additional 201 shares during the period. Massmutual Trust Co. FSB ADV grew its position in shares of Leidos by 122.5% in the second quarter. Massmutual Trust Co. FSB ADV now owns 307 shares of the aerospace company’s stock valued at $45,000 after purchasing an additional 169 shares during the last quarter. Family Firm Inc. bought a new position in shares of Leidos during the second quarter worth approximately $60,000. Finally, Tributary Capital Management LLC acquired a new stake in Leidos during the 1st quarter worth approximately $64,000. 76.12% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling at Leidos
In related news, Director Gary Stephen May sold 1,000 shares of Leidos stock in a transaction that occurred on Tuesday, August 13th. The stock was sold at an average price of $144.02, for a total transaction of $144,020.00. Following the transaction, the director now owns 11,264 shares of the company’s stock, valued at $1,622,241.28. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In related news, Director Gary Stephen May sold 1,000 shares of the company’s stock in a transaction that occurred on Tuesday, August 13th. The stock was sold at an average price of $144.02, for a total value of $144,020.00. Following the transaction, the director now owns 11,264 shares in the company, valued at $1,622,241.28. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Robert C. Kovarik, Jr. sold 1,059 shares of Leidos stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $145.23, for a total value of $153,798.57. Following the completion of the transaction, the director now owns 7,455 shares of the company’s stock, valued at $1,082,689.65. The disclosure for this sale can be found here. Company insiders own 0.96% of the company’s stock.
Leidos Price Performance
Leidos (NYSE:LDOS – Get Free Report) last posted its quarterly earnings results on Tuesday, July 30th. The aerospace company reported $2.63 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.27 by $0.36. Leidos had a net margin of 2.72% and a return on equity of 28.40%. The business had revenue of $4.13 billion during the quarter, compared to the consensus estimate of $4.06 billion. During the same quarter last year, the firm posted $1.80 EPS. Leidos’s revenue was up 7.7% compared to the same quarter last year. Equities research analysts anticipate that Leidos Holdings, Inc. will post 8.95 earnings per share for the current fiscal year.
Leidos Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, September 27th. Investors of record on Friday, September 13th were issued a $0.38 dividend. The ex-dividend date of this dividend was Friday, September 13th. This represents a $1.52 dividend on an annualized basis and a dividend yield of 0.92%. Leidos’s dividend payout ratio is presently 65.52%.
Wall Street Analyst Weigh In
LDOS has been the subject of a number of recent research reports. Wells Fargo & Company boosted their target price on shares of Leidos from $172.00 to $183.00 and gave the company an “overweight” rating in a research report on Tuesday. Royal Bank of Canada lifted their price target on shares of Leidos from $140.00 to $145.00 and gave the company a “sector perform” rating in a research report on Wednesday, July 31st. JPMorgan Chase & Co. raised their price objective on Leidos from $165.00 to $175.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 31st. Citigroup upped their target price on Leidos from $165.00 to $169.00 and gave the company a “buy” rating in a research report on Wednesday, July 31st. Finally, Bank of America boosted their price objective on shares of Leidos from $160.00 to $165.00 and gave the company a “buy” rating in a research report on Wednesday, August 7th. Two research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, Leidos presently has a consensus rating of “Moderate Buy” and a consensus price target of $164.00.
Check Out Our Latest Stock Report on LDOS
Leidos Profile
Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.
See Also
- Five stocks we like better than Leidos
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Why Lennar Stock Could Be the Best Play in the Housing Market
- High Dividend REITs: Are They an Ideal Way to Diversify?
- 2 Energy Stocks Fueling the AI Datacenter Boom
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Leidos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Leidos and related companies with MarketBeat.com's FREE daily email newsletter.